vs
卡博特（CBT）与Healthpeak Properties（DOC）财务数据对比。点击上方公司名可切换其他公司
卡博特的季度营收约是Healthpeak Properties的1.2倍（$849.0M vs $719.4M），Healthpeak Properties净利率更高（73.2% vs 8.6%，领先64.6%），Healthpeak Properties同比增速更快（3.1% vs -11.1%），Healthpeak Properties自由现金流更多（$357.0M vs $57.0M），过去两年Healthpeak Properties的营收复合增速更高（8.9% vs -8.7%）
卡博特公司是总部位于美国马萨诸塞州波士顿的特种化学品和高性能材料企业，业务覆盖全球20多个国家，拥有36座生产工厂、8个研发中心及28个销售办事处，在特种材料领域具备全球领先的技术和服务能力。
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
CBT vs DOC — 直观对比
营收规模更大
CBT
是对方的1.2倍
$719.4M
营收增速更快
DOC
高出14.2%
-11.1%
净利率更高
DOC
高出64.6%
8.6%
自由现金流更多
DOC
多$300.0M
$57.0M
两年增速更快
DOC
近两年复合增速
-8.7%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $849.0M | $719.4M |
| 净利润 | $73.0M | $114.0M |
| 毛利率 | 24.9% | — |
| 营业利润率 | 15.2% | 17.4% |
| 净利率 | 8.6% | 73.2% |
| 营收同比 | -11.1% | 3.1% |
| 净利润同比 | -21.5% | 2406.4% |
| 每股收益（稀释后） | $1.37 | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CBTDOC
| Q4 25 | $849.0M | $719.4M | ||
| Q3 25 | $899.0M | $705.9M | ||
| Q2 25 | $923.0M | $694.3M | ||
| Q1 25 | $936.0M | $702.9M | ||
| Q4 24 | $955.0M | $698.0M | ||
| Q3 24 | $1.0B | $700.4M | ||
| Q2 24 | $1.0B | $695.5M | ||
| Q1 24 | $1.0B | $606.6M |
净利润CBTDOC
| Q4 25 | $73.0M | $114.0M | ||
| Q3 25 | $43.0M | $-117.1M | ||
| Q2 25 | $101.0M | $31.7M | ||
| Q1 25 | $94.0M | $42.8M | ||
| Q4 24 | $93.0M | $4.5M | ||
| Q3 24 | $137.0M | $85.9M | ||
| Q2 24 | $109.0M | $146.0M | ||
| Q1 24 | $84.0M | $6.7M |
毛利率CBTDOC
| Q4 25 | 24.9% | — | ||
| Q3 25 | 24.5% | 58.6% | ||
| Q2 25 | 26.4% | 60.2% | ||
| Q1 25 | 25.7% | 61.1% | ||
| Q4 24 | 24.6% | 60.3% | ||
| Q3 24 | 24.0% | 60.0% | ||
| Q2 24 | 25.2% | 60.6% | ||
| Q1 24 | 24.1% | 59.8% |
营业利润率CBTDOC
| Q4 25 | 15.2% | 17.4% | ||
| Q3 25 | 15.2% | 9.2% | ||
| Q2 25 | 18.1% | 5.7% | ||
| Q1 25 | 17.3% | 7.7% | ||
| Q4 24 | 16.2% | -2.2% | ||
| Q3 24 | 15.0% | 14.1% | ||
| Q2 24 | 16.9% | 22.3% | ||
| Q1 24 | 15.3% | 3.7% |
净利率CBTDOC
| Q4 25 | 8.6% | 73.2% | ||
| Q3 25 | 4.8% | -16.6% | ||
| Q2 25 | 10.9% | 4.6% | ||
| Q1 25 | 10.0% | 6.1% | ||
| Q4 24 | 9.7% | 0.7% | ||
| Q3 24 | 13.7% | 12.3% | ||
| Q2 24 | 10.7% | 21.0% | ||
| Q1 24 | 8.2% | 1.1% |
每股收益（稀释后）CBTDOC
| Q4 25 | $1.37 | $0.16 | ||
| Q3 25 | $0.80 | $-0.17 | ||
| Q2 25 | $1.86 | $0.05 | ||
| Q1 25 | $1.69 | $0.06 | ||
| Q4 24 | $1.67 | $0.02 | ||
| Q3 24 | $2.41 | $0.12 | ||
| Q2 24 | $1.94 | $0.21 | ||
| Q1 24 | $1.49 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $230.0M | $467.5M |
| 总债务越低越好 | — | $9.8B |
| 股东权益账面价值 | $1.6B | $7.5B |
| 总资产 | $3.8B | $20.3B |
| 负债/权益比越低杠杆越低 | — | 1.31× |
8季度趋势，按日历期对齐
现金及短期投资CBTDOC
| Q4 25 | $230.0M | $467.5M | ||
| Q3 25 | $258.0M | $91.0M | ||
| Q2 25 | $239.0M | $89.4M | ||
| Q1 25 | $213.0M | $70.6M | ||
| Q4 24 | $183.0M | $119.8M | ||
| Q3 24 | $223.0M | $180.4M | ||
| Q2 24 | $197.0M | $106.9M | ||
| Q1 24 | $206.0M | $101.8M |
总债务CBTDOC
| Q4 25 | — | $9.8B | ||
| Q3 25 | $1.1B | $9.1B | ||
| Q2 25 | — | $9.0B | ||
| Q1 25 | — | $8.9B | ||
| Q4 24 | — | $8.7B | ||
| Q3 24 | $1.1B | $8.6B | ||
| Q2 24 | — | $8.6B | ||
| Q1 24 | — | $8.8B |
股东权益CBTDOC
| Q4 25 | $1.6B | $7.5B | ||
| Q3 25 | $1.6B | $7.6B | ||
| Q2 25 | $1.5B | $7.9B | ||
| Q1 25 | $1.4B | $8.2B | ||
| Q4 24 | $1.4B | $8.4B | ||
| Q3 24 | $1.4B | $8.6B | ||
| Q2 24 | $1.3B | $8.8B | ||
| Q1 24 | $1.4B | $8.9B |
总资产CBTDOC
| Q4 25 | $3.8B | $20.3B | ||
| Q3 25 | $3.8B | $19.6B | ||
| Q2 25 | $3.8B | $19.8B | ||
| Q1 25 | $3.8B | $19.8B | ||
| Q4 24 | $3.6B | $19.9B | ||
| Q3 24 | $3.7B | $20.0B | ||
| Q2 24 | $3.6B | $20.2B | ||
| Q1 24 | $3.6B | $20.5B |
负债/权益比CBTDOC
| Q4 25 | — | 1.31× | ||
| Q3 25 | 0.70× | 1.20× | ||
| Q2 25 | — | 1.14× | ||
| Q1 25 | — | 1.08× | ||
| Q4 24 | — | 1.04× | ||
| Q3 24 | 0.75× | 1.00× | ||
| Q2 24 | — | 0.98× | ||
| Q1 24 | — | 0.99× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $126.0M | $1.3B |
| 自由现金流经营现金流 - 资本支出 | $57.0M | $357.0M |
| 自由现金流率自由现金流/营收 | 6.7% | 49.6% |
| 资本支出强度资本支出/营收 | 8.1% | 124.4% |
| 现金转化率经营现金流/净利润 | 1.73× | 10.99× |
| 过去12个月自由现金流最近4个季度 | $401.0M | — |
8季度趋势，按日历期对齐
经营现金流CBTDOC
| Q4 25 | $126.0M | $1.3B | ||
| Q3 25 | $219.0M | $315.0M | ||
| Q2 25 | $249.0M | $363.5M | ||
| Q1 25 | $73.0M | $279.4M | ||
| Q4 24 | $124.0M | $1.1B | ||
| Q3 24 | $204.0M | $318.2M | ||
| Q2 24 | $207.0M | $316.2M | ||
| Q1 24 | $176.0M | $152.6M |
自由现金流CBTDOC
| Q4 25 | $57.0M | $357.0M | ||
| Q3 25 | $155.0M | — | ||
| Q2 25 | $188.0M | — | ||
| Q1 25 | $1.0M | — | ||
| Q4 24 | $47.0M | $333.7M | ||
| Q3 24 | $112.0M | — | ||
| Q2 24 | $155.0M | — | ||
| Q1 24 | $133.0M | — |
自由现金流率CBTDOC
| Q4 25 | 6.7% | 49.6% | ||
| Q3 25 | 17.2% | — | ||
| Q2 25 | 20.4% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 4.9% | 47.8% | ||
| Q3 24 | 11.2% | — | ||
| Q2 24 | 15.3% | — | ||
| Q1 24 | 13.1% | — |
资本支出强度CBTDOC
| Q4 25 | 8.1% | 124.4% | ||
| Q3 25 | 7.1% | — | ||
| Q2 25 | 6.6% | — | ||
| Q1 25 | 7.7% | — | ||
| Q4 24 | 8.1% | 105.6% | ||
| Q3 24 | 9.2% | — | ||
| Q2 24 | 5.1% | — | ||
| Q1 24 | 4.2% | — |
现金转化率CBTDOC
| Q4 25 | 1.73× | 10.99× | ||
| Q3 25 | 5.09× | — | ||
| Q2 25 | 2.47× | 11.48× | ||
| Q1 25 | 0.78× | 6.52× | ||
| Q4 24 | 1.33× | 235.43× | ||
| Q3 24 | 1.49× | 3.71× | ||
| Q2 24 | 1.90× | 2.17× | ||
| Q1 24 | 2.10× | 22.85× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CBT
| Reinforcement Materials | $520.0M | 61% |
| Performance Chemicals | $300.0M | 35% |
| Shipping And Handling | $25.0M | 3% |
| Other Products And Services | $4.0M | 0% |
DOC
暂无分部数据
